ISRCTN11560295
Completed
N/A
Prognostic biomarkers in prostate cancer identified through bioinformatic analysis
Sichuan University0 sites3,000 target enrollmentDecember 1, 2021
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Prognostic markers of prostate cancer
- Sponsor
- Sichuan University
- Enrollment
- 3000
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36217461/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35280985/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36109820/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35463369/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36144737/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35658892/ (added 06/01/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35096608/ (added 06/01/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with prostate cancer in the TCGA and GEO databases
Exclusion Criteria
- •Patients without prognostic information in the TCGA and GEO databases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Identification of Predictive BiomarkersProstate Cancer RecurrentNCT04324983Martini-Klinik am UKE GmbH150
Unknown
N/A
Biomarkers in Prostate Cancer Treated With SRP Following Failure of FATProstatic NeoplasmsNCT03533998Institut Mutualiste Montsouris30
Completed
N/A
Prostate Cancer Upgrading Reference SetProstate CancerNCT02189486The University of Texas Health Science Center at San Antonio382
Active, Not Recruiting
N/A
Early vs. delayed screening for prostate cancerISRCTN37591328German Cancer Aid46,000
Completed
N/A
Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss PopulationProstate CancerLocalized CarcinomaNCT05294627University Hospital, Basel, Switzerland380